Literature DB >> 181309

Pituitary and extrapituitary effects of somatostatin in normal man.

G Copinschi, V Leclercq-Meyer, E Virasoro, M L'Hermite, L Vanhaelst, J Golstein, R Leclercq, F Féry, C Robyn.   

Abstract

The effects of synthetic linear somatostatin on basal circulating levels on several pituitary and pancreatic hormones, and of glucose and free fatty acids (FFA) were studied in 6 normal men after an overnight fast. A priming intravenous infusion of 250 mug of somatostatin in 18 sec was followed by a constant infusion of 500 mug over a period of 60 min. A decrease in plasma values of GH, prolactin, TSH, insulin and glucagon and in blood glucose was observed during somatostatin infusion, while FFA levels increased progressively. Plasma IRI and blood glucose increased rapidly when the somatostatin infusion was stopped, while FFA decreased progressively; GH, prolactin, TSH and glucagon remained low as compared to basal levels for one hour after the end of the infusion, i.e. until the end of the experiment. A slight but significant increase of LH and ACTH was observed after the end of the infusion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181309     DOI: 10.1055/s-0028-1093646

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

2.  The hyperinsulinaemic hypoglycaemias in infancy: a study of six cases.

Authors:  P Amendt; K D Kohnert; J Kunz
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

3.  Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.

Authors:  M Andersen; T B Hansen; J Bollerslev; P Bjerre; H D Schrøder; C Hagen
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

4.  High concentration of thyrotropin-releasing hormone in pancreatic islets.

Authors:  E Martino; A Lernmark; H Seo; D F Steiner; S Refetoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

5.  Ultrastructural changes rapidly induced by somatostatin may inhibit prolactin release in estrogen-primed rat adenohypophysis.

Authors:  S L Saunders; C W Reifel; S H Shin
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.